Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
AHK-Cu is a copper-binding tripeptide (alanyl-histidyl-lysine complexed with copper) used as a research reference material
Unlike peptides that require syringes or compounding pharmacies, Healthletic BPC-157 comes in easy-to-swallow capsules
Bacteriostatic water provides a stable environment that supports gradual, uniform mixing without introducing unwanted contaminants
2 Results 2.1 Pharmacokinetic studies of BPC157 in rats The effective dose of BPC157 for the treatment of various injuries in mice, rats, and rabbits ranges from 6 to 50 g/kg ( The mean (+SD) plasma concentration of BPC157 versus time curves following administration of various BPC157 doses in rats are shown in Figures 1AC, and the corresponding pharmacokinetic parameters are presented in Tables 1Tables 3
In clinical use, the most commonly reported side effects are: Mild injection site redness or swelling (resolves within hours) Occasional lightheadedness following injection (less common, position-dependent) Temporary nausea with oral administration in some patients Who should not use BPC-157: Patients with active cancer or a history of cancer should discuss BPC-157 carefully with their oncologist before use angiogenic peptides theoretically could support tumor vascularity, though no evidence of this has been demonstrated in animals
A pharmacist assessment is required before every treatment
